FNY Investment Advisers’s Janux Therapeutics JANX Stock Holding History

FNY Investment Advisers’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$473K	Buy	30,850 +140	+0.5%	+$2.03K	0.17%	156
2026 Q1	$426K	Buy	30,710 +20,410	+198%	+$280K	0.19%	118
2025 Q4	$142K	Buy	10,300 +5,090	+98%	+$120K	0.04%	290
2025 Q3	$127K	Hold	5,210	–	–	0.04%	344
2025 Q2	$120K	Buy	5,210 +2,750	+112%	+$72.5K	0.05%	279
2025 Q1	$66K	Buy	2,460 +2,425	+6,929%	+$91.4K	0.04%	257
2024 Q4	$1K	Sell	35 -565	-94%	-$29.9K	﹤0.01%	622
2024 Q3	$27K	Sell	600 -50	-8%	-$2.17K	0.01%	352
2024 Q2	$27K	Buy	+650	New	+$30.5K	0.02%	284

Other funds holding JANX

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

FNY Investment Advisers's JANX Position: Q2 2026 in Review

FNY Investment Advisers increased its Janux Therapeutics (JANX) stake by 0.46% in Q2 2026, buying an estimated $2.03K and bringing the position to 30,850 shares worth $473K. The position accounts for 0.17% of the portfolio, ranked #156.

FNY Investment Advisers first reported a position in JANX in Q2 2024 and has held it in 9 quarters since. 29 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

FNY Investment Advisers held 30,850 shares of Janux Therapeutics worth $473K as of Q2 2026.
FNY Investment Advisers bought 140 Janux Therapeutics shares in Q2 2026, an estimated $2.03K.
Janux Therapeutics made up 0.17% of FNY Investment Advisers's portfolio in Q2 2026, its #156 holding.
FNY Investment Advisers first reported a position in Janux Therapeutics in Q2 2024 and has held it in 9 quarters since.
29 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.